Kontich, Belgium, 23 June 2023 Flen Health is proud to announce that it has been awarded a 1.7 million research and development grant by the Flanders Innovation & Entrepreneurship (VLAIO – for short) to leverage further its leading expertise in biological wound treatment research and development. The award represents the funding at approximately 60% of a 3.0 million project. Funding from the grant will serve to further accelerate the deployment of Flen Health’s unique Enzyme technology and research platform and will lead to a deeper understanding of recombinant engineering and the development of unique and novel biological enzyme-based treatments for non-healing and chronic wounds. Enabling cross-fertilizing the company’s growing pipeline of patented and breakthrough candidate drugs in wound and skin care. Gilles Brackman, Vice President of Research & Development of Flen Health, commented, “I am honoured by the recognition and financial support from VLAIO and pleased to contribute to their commitment to stimulate Biotechnological research and development in Flanders, Belgium. This grant allows us to further strengthen our enzyme-technology platform capabilities and represent an important accelerator in the further development of enzyme-based biopharmaceuticals for the treatment of chronic and difficult-to-heal wounds. This will position Flen Health as a true innovative wound and skincare company with multiple shots at goal.” “I am thrilled that VLAIO has recognized the breakthrough science that we undertake at Flen Health which endorses the quality level of our research projects,” said Philippe Sollie, CEO of Flen Health. “This grant is a support for our project to manufacture enzymes at a pharmaceutical quality level. Executing this project will do even more than that. With this project, we are creating at Flen Health a platform technology for the identification, GMP manufacturing and registration of therapeutic proteins that transform the lives of patients with wounds and skin diseases. We are well on track to further push our extraordinary goal and provide patients across the globe with our innovative transformative treatments that help these patients live the life they love” he concluded. Flen Health remains committed to its mission of advancing wound and skin healing through groundbreaking research, and this grant from VLAIO will play a pivotal role in shaping the future of the company's ongoing work. About Flen Health Flen Health is an international family enterprise with affiliates in Europe and the United States and strategic partnerships and distributor agreements worldwide. These allow Flen Health to develop and market medical devices and pharmaceutical products that meet its original mission of providing innovative skin and wound healing solutions to address unmet patient needs. In recent years, Flen Health was labelled as an EU innovative company and has secured millions of non-dilutive funding for R&D activities within its innovation centres and in collaboration with academic and institutional partners.
Esch-sur-Alzette, 12 January 2023 - The House of Biohealth (HoBH) proudly celebrated the inauguration of its third building yesterday, marking a significant milestone in the growth of the biomedical industry in Esch-sur-Alzette. Flen Health, a leading provider of innovative skin and woundcare solutions, is delighted to have been chosen as one of the three companies, among the twenty present on the site, to receive the esteemed visit of H.R.H. Crown Prince Guillaume of Luxembourg, Paulette Lenert, Minister of Health, Franz Fayot, Minister of Economy, Georges Mischo, Mayor of Esch-sur-Alzette, Simone Asselborn-Bintz, Mayor of Sanem, and Jeannot Fürpass, Mayor of Mondercange. During the inauguration ceremony, Flen Health had the privilege of hosting the distinguished delegation in its laboratory. Philippe Sollie, CEO of Flen Health, and Gilles Brackman, VP of Research and Development, were granted the opportunity to showcase the company's cutting-edge research activities and innovative products. The compelling presentation captivated the interest and curiosity of H.R.H. Crown Prince Guillaume, particularly regarding Flen Health's ground-breaking solutions in the fields of skin and woundcare. Flen Health holds a special place in the history of the House of Biohealth. In 2015, when the first building was inaugurated, Flen Health became the pioneering company to establish its presence within the HoBH in Esch-sur-Alzette. The House of Biohealth serves as a hub for companies focused on biotechnology and digital health technologies, playing a pivotal role in the "Campus He:al" project. This ambitious venture includes the construction of a dozen new structures and the provision of 120,000 square meters of business space. Over the next 10 to 15 years, the campus is set to flourish and become a vibrant center of innovation and collaboration. Flen Health extends its gratitude to H.R.H. Crown Prince Guillaume of Luxembourg, the esteemed delegation, and the House of Biohealth for the honor of their visit. This significant event reaffirms Flen Health's commitment to advancing healthcare through groundbreaking research and development, and its dedication to contributing to the thriving biomedical community in Esch-sur-Alzette.
"After the crisis we will find out that COVID-19 has changed our lives substantially", Philippe Sollie, CEO, Flen Health. Join us for a first-hand look at the impact of the global shutdown following the corona virus outbreak. "We should continue to focus on building international ties & to find solutions in this new reality", Philippe Sollie. EACC New York creates together with its members a video series of first-hand accounts of the Pandemic’s impact, both personally & professionally. Philippe Sollie answered the following questions to EACCNY: 1) What are some challenges you, personally and your organization have faced? 2) What are some of the most surprising (positive, innovative) responses/changes you have witnessed? 3) How will this experience change us going forward, as a society and in terms of how we do business? EACCNY has its finger on the pulse of how this worldwide pandemic is affecting companies and organisations on both sides of the Atlantic. EACC is where Americans & Europeans connect to do business. Please find more video series of first-hand accounts of the Pandemic’s impact here.
What a wonderful surprise! Two Consumer Healthcare Communication Awards (CHCA) have been awarded to Flamigel® in the categories Best User Friendly Campaign and Most Efficient Campaign. Thank you to all loyal fans, consumers and pharmacists who voted for Flamigel®! BACHI initiates the CHCA and the award ceremony took place on January 16th in Brussels. We are so proud and we will continue to give our best in 2020!
20 years of turning research into effective skin and wound healing solutions Brussels, January 2020: Flen Health proudly announces its 20-year anniversary. Starting in 2000 as a one-man Belgian operation, the company has grown to an international family enterprise with market-leading positions and over 100 motivated employees. “By listening to patients, working hand in hand with healthcare professionals and continuously investing our efforts in research and development the company has grown and established itself as an innovative provider of solutions to the health care market”, explains Philippe Sollie, founder and CEO, Flen Health. Today, the company is represented by two headquarters with innovation centres in Belgium and Luxembourg. Further affiliates are located in the Netherlands, Germany, UK, US and UAE. The company’s product portfolio is constantly growing and follows a biotechnological approach to protect what is good in the wound and eliminate what is bad, thus providing what is needed for a wound to heal. All efforts are based on the objective to turn research into effective, safe plus easy-to-use skin and wound healing solutions. In order to follow this objective Flen Health continuously translates expertise from patients and healthcare professionals into new technologies for a healthier skin. “Our slogan ‘creating with You in mind’ is founded on my experience and is at the heart of our daily operations. Only if we work closely with the ones using our products, are we able to identify unmet needs and provide the right solutions”, believes Philippe Sollie. Prior to 2000, Philippe worked as a pharmacist in Belgium. Following an accident where his friend’s little daughter suffered severe burns and a subsequent allergic reaction to existing treatment products, he wanted to help. Together with the Head of the Antwerp Burns Centre, Philippe developed Flamigel® which continues to prove its wound healing effectiveness. This positive experience led to the foundation of Flen Health and has since generated many more patient success stories. It is these patient successes that give us cause to celebrate and the motivation to continue to create innovation with You in mind. Flen Health has been labelled EU innovative company and has secured several research grants. “The success we have had in obtaining non-dilutive funding for research, our ability to construct strong, sustainable partnerships and agreements with academic as well as non-academic partners both inside and outside of Europe in the past 20 years, demonstrate that we are respected for our expertise and for our vision for the future”, states Gilles Brackman, Vice President R&D, Flen Health. Thank You for Your trust in us, today and tomorrow. About Flen Health Flen Health believes biotech innovations can help to build a securer life for all of us. With its product portfolio Flen Health aims to improve the quality of life of people suffering from inflammatory or infectious skin diseases in a responsible way, by providing added value for patients, healthcare professionals and health authorities. Learn more about Flen Health
"Being told that one has Cancer is not much fun, and when I was diagnosed nearly 18 months ago it was inevitably a shock. This was compounded by the certainty of an operation (double mastectomy), possibility of chemotherapy and almost certainty of Radiotherapy." The Chemo I escaped, the operation went well, but it was the anticipation of the Radiotherapy which, for me, presented the worst fears. It was not a fear of ‘nuclear medicine’, it was the side-effects: I was almost promised these...blistering, weeping skin, bright red and extremely itchy patches around the treated areas. The fact that these things would blow up AFTER the treatment was ended made it seem worse, treatment that in itself was fairly grim - having to lie unnaturally still for what seemed like ages: having one’s body heaved around to ‘position’ it and not being allowed to help - incredibly undignified. It was just before I started Radiotherapy, however, that I was introduced to someone who had travelled an identical path to mine, and she swore by Flamigel® RT, a cream that had been given to her by the hospital where she had undertaken her cancer treatment. It was prescription only, but when I asked Guy’s for one, they denied all knowledge of it, and continued to ‘sell’ E45. Eventually our GP, himself a ‘skin man’, agreed that Flamigel® was the route to take. About four days into my Radiotherapy I switched from E45 to Flamigel® RT. And I have not looked back... I have had NONE of the promised nasties, no weeping skin, no blistering effects like sunburn. Yes, three weeks after I finished treatment two angry red patches appeared around my collar bone but they only itch a tiny bit, easily soothed by a quick application of Flamigel®, and I expect them to go away soon. And the cream doesn’t smell, it leaves no stain on clothing and is very quickly absorbed. Most importantly, of course, it WORKS and I had none of the miseries that I had anticipated. Cancer is a horrible and frightening thing to have, but it makes a huge difference to have something which so effectively eases the many irritants which its treatment seem to generate. I sincerely hope that Flamigel® RT will soon be widely and easily available to ALL those unfortunate enough to have to undergo the rigours of Radiotherapy.” Speaking about terrifying memories takes a lot of courage and strength therefore we very much appreciate that Sarah told us her story. Thank you for your trust Sarah!
